The SARS-CoV-2–neutralizing capacity of kidney transplant recipients 4 weeks after receiving a second dose of the BNT162b2 vaccine
Rune M. Pedersen, Line L. Bang, Ditte S. Tornby, Helene Kierkegaard, Anna Christine Nilsson, Işık Somuncu Johansen, Claus Bistrup, Thøger Gorm Jensen, Ulrik Stenz Justesen, Thomas Emil Andersen
Topics & Concepts
MedicineSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakKidney transplantVirologyKidney transplantationKidneyInternal medicineInfectious disease (medical specialty)OutbreakDiseaseSARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesAnimal Virus Infections Studies